Log In
Print this Print this

GSK1292263 (1292263)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionGastrin-releasing peptide (GRP) receptor agonist
Molecular Target Gastrin-releasing peptide receptor (GRP-R) (BB2)
Mechanism of ActionGastrin-releasing peptide receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today